InSitu Biologics, Inc.

Amendment
CIK: 0001723443·Biotechnology·DELAWARE·Filed: Nov 10, 2026
Total Offering

$19,837,423

Amount Sold

$15,037,850

Investors

27

First Sale

Oct 14, 2022

Offering Details

Type
Debt, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Daniel Halpern
Related Person
William Taylor
Related Person
Sandi Klemann
Related Person
Robert Wilson
Related Person
Greg Van Guilder
Related Person
Ivan Shaw
Related Person

Company

InSitu Biologics, Inc.

3510 HOPKINS PLACE N.

OAKDALE, MN, 55128

651-337-4799

SEC Filing

0001723443-26-000008

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free